Stroke complicating transcatheter aortic valve implantation: Incidence, risk factors and outcome

International Journal of Stroke

Volumn 8, Issue 4, 2013, Pages 235-239

  Leker, Ronen R ^a   Eichel, Roni ^a   Verber, Ami ^a   Cohen, Jose E ^a   Lotan, Chaim ^a   Danenberg, Haim D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Aortic valve; Catheterization; Cerebrovascular disease; Stroke

Indexed keywords

AGED; ARTICLE; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; AORTIC VALVE; CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84878179116     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00804.x     Document Type: Article

References (29)

1. Hamon M, Baron JC, Viader F, Hamon M. Periprocedural stroke and cardiac catheterization. Circulation 2008; 118 : 678-683.
2. Leker RR, Pollak A, Abramsky O, Ben-Hur T. Abundance of left hemispheric embolic strokes complicating coronary angiography and PTCA. J Neurol Neurosurg Psychiatry 1999; 66 : 116-117.
3. Cribier A, Eltchaninoff H, Bash A etal. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106 : 3006-3008.
4. Cribier A, Eltchaninoff H, Tron C etal. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43 : 698-703.
5. Grube E, Buellesfeld L, Mueller R etal. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008; 1 : 167-175.
6. Webb JG, Pasupati S, Humphries K etal. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116 : 755-763.
7. Ben-Dor I, Waksman R, Satler LF, Pichard AD. Patient selection - risk assessment and anatomical selection criteria for patients undergoing transfemoral aortic valve implantation. Cardiovasc Revasc Med 2010; 11 : 124-136.
8. Grube E, Laborde JC, Gerckens U etal. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114 : 1616-1624.
9. Rodes-Cabau J, Webb JG, Cheung A etal. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55 : 1080-1090.
10. Kahlert P, Knipp SC, Schlamann M etal. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121 : 870-878.
11. Stolz E, Gerriets T, Kluge A, Klovekorn WP, Kaps M, Bachmann G. Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future neuroprotective trials? Stroke 2004; 35 : 888-892.
12. Webb JG. Transcatheter aortic valve implantation. Balancing enthusiasm and caution. Rev Esp Cardiol 2010; 63 : 131-133.
13. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009; 53 : 1829-1836.
14. Buellesfeld L, Wenaweser P, Gerckens U etal. Transcatheter aortic valve implantation: predictors of procedural success - the Siegburg-Bern experience. Eur Heart J 2010; 31 : 984-991.
15. Cribier A, Eltchaninoff H, Tron C etal. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006; 47 : 1214-1223.
16. Omran H, Schmidt H, Hackenbroch M etal. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361 : 1241-1246.
17. Piazza N, Grube E, Gerckens U etal. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) Corevalve Revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4 : 242-249.
18. Van Brabandt H, Neyt M. Safety of percutaneous aortic valve insertion. A systematic review. BMC Cardiovasc Disord 2009; 9 : 45-51.
19. Van Mieghem NM, Nuis RJ, Piazza N etal. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 2010; 5 : 673-679.
20. Webb JG, Chandavimol M, Thompson CR etal. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113 : 842-850.
21. Ghanem A, Muller A, Nahle CP etal. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010; 55 : 1427-1432.
22. Floyd TF, Shah PN, Price CC etal. Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg 2006; 81 : 2160-2166.
23. Knipp SC, Matatko N, Schlamann M etal. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005; 28 : 88-96.
24. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1, 000 cases. J Am Coll Cardiol 1998; 32 : 1861-1865.
25. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996; 334 : 1216-1221.
26. Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke. Stroke 2009; 40 : 713-718.
27. Russo C, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR. Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study. Stroke 2009; 40 : 2313-2318.
28. Leite Filho OA, Brandao CM, Pomerantzeff PM, Guedes MA, Higuchi Mde L, Stolf NA. Particulate emboli capture by an intra-aortic filter device during aortic valve replacement. Rev Bras Cir Cardiovasc 2008; 23 : 431-435.
29. Kofidis T, Fischer S, Leyh R etal. Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg 2002; 21 : 22-26.